VIDEO

FindCenter AddIcon

There Is No Such Thing as a “Bad Drug” | Psychedcast Ft. Mark Haden

By Mark Haden — 2020

Mark Haden is the executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS) Canada as well as an adjunct professor at the University of British Columbia School of Public and Population Health.

30:35 min

03:03

Breakthrough for Psychedelic Medicine

FindCenter AddIcon
37:04

Rick Doblin & Natalie Ginsberg: Rescheduling MDMA - History, Present and Future

Natalie Ginsberg, MAPS Policy and Advocacy Manager will interview Rick Doblin, Ph.D.

FindCenter AddIcon
37:04

Horizons 2016 | Rick Doblin, PhD, and Natalie Ginsberg: “Rescheduling MDMA—History, Present, and Future”

Natalie Ginsberg, MAPS Policy and Advocacy Manager will interview Rick Doblin, Ph.D.

FindCenter AddIcon
06:25

Sanjay Gupta MD: Psychedelic Medicine Gets a Closer Look

Drugs like LSD and MDMA are generating new interest among doctors for use in psychotherapy.

FindCenter AddIcon
01:09:33

Psychedelics Impact on Society | Rick Doblin, Ph.D. | Talks at Google

Rick Doblin - "Psychedelics: Mystical Experiences, Cultural Evolution, Non-Profit MDMA/PTSD Research, and Burning Man" Rick Doblin, the co-founder and CEO of the Multidisciplinary Association for Psychedelic Studies (MAPS, www.maps.

FindCenter AddIcon
16:33

The Future of Psychedelic-Assisted Psychotherapy | Rick Doblin

Could psychedelics help us heal from trauma and mental illnesses? Researcher Rick Doblin has spent the past three decades investigating this question, and the results are promising.

FindCenter AddIcon
34:30

Amanda Feilding: LSD, Precious Key of Neuroscience | The Beckley Foundation

The Beckley Foundation Scientific Program conducts cutting edge research with LSD in human subjects, explores neurophysiological similarities between LSD and the mystical experience through observing modulations in the blood supply, brainwaves and a broad spectrum of cognitive changes.

FindCenter AddIcon

EXPLORE TOPIC

Drug Policy